Gimon de Graaf
Medior Researcher, Institute for Medical Technology Assessment
Gimon de Graaf is a researcher with a particular expertise in value assessment of products that are still in development. During his PhD he developed new methods for the early evaluation of diagnostics to support investment and R&D decisions. He has many years of experience as a consultant to pharmaceutical and medical device companies. In addition, he published several papers in international peer reviewed journals in the field of health technology assessment and contributed on a number of scientific advisory panels. If you have any questions regarding the value or the potential cost-effectiveness of your innovation, or how to steer development towards maximizing these, be sure to speak to Gimon during the conference
Keywords: health economics, value based health care, cost-effectiveness, health technology assessment, value strategy consulting.
Market regulators are increasingly critical towards the price of new health care products. Meanwhile, value based health care is gaining interest with health care professionals. This calls for a thorough understanding of the value of your innovation. At the institute for Medical Technology Assessment (iMTA), founded in 1988, we can build upon decades of experience in the economic evaluation of medical devices and pharmaceuticals to help you build a well founded value story for your product